1. Catalog
  2. GREPNSEM2501 - CME/CMLE - Current NSCLC Biomarker ...
Image For Activity Cover
GREPNSEM2501 - CME/CMLE - Current NSCLC Biomarker Testing Guidelines
Course Description

Current NSCLC Biomarker Testing Guidelines 

Activity Description: 

This microlearning activity is part of a case-based series designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving biomarker testing and treatment for NSCLC. This specific course focuses on biomarker testing guidelines and best practices for biomarker testing across stages of NSCLC.   

Course topics include: 

  • Biomarkers for NSCLC therapies 

  • Clinical Staging and Biomarker Testing 

  • Testing Assays 

  • Summary of Current Guidelines   

Target Audience

This activity has been designed to meet the educational needs of pathologists and laboratory professionals.    

Faculty/Authors:

Haodong Xu
Director, Anatomic Pathology, Professor of Pathology, Internal Medicine, and Cardiovascular Medicine 
Wake Forest University
Winston-Salem, NC 

Physician Competencies: 
Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement 

Credit Designation Statement 

The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  

ASCP designates this activity for a maximum of .25 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT. 

 

Method of Participation
To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided online.  

Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc. 


Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 2/3/2025        
Review Date:
Expiration Date: 2/3/2028    




Course Objectives

Upon completion of this activity, you will be able to:

  • Understand the significance of biomarker testing in the diagnosis and treatment of NSCLC 

  • Identify key biomarkers including EGFR, ALK, and PD-L1, and their roles in NSCLC therapies 

  • Describe the relationship between clinical staging and the selection of biomarker testing strategies 

  • Explain the current clinical guidelines for biomarker testing in NSCLC 

Summary
Availability: On-Demand
Credit Offered:
0.25 CME/CMLE Credit
Powered By